The NIHR is the nation's largest funder of health and care research and provides the people, facilities and technology that enable research to thrive. We work in partnership with the NHS, universities, local government, other research funders (including industry and charities), patients and the public to improve the health and wealth of the nation.
The NIHR Clinical Research Network (CRN) supported 747 studies on children and young people, 251 of which were new studies, and recruited 127,960 patients to studies last year (2018/19).
The first-choice flu vaccine (known as LAIV) is the most effective available and is administered through a nasal spray, which most parents and children prefer to an injection. However it can contain small amounts of egg protein, meaning that it was previously considered unsuitable for children with an egg allergy. Egg allergy is one of the most common allergies in early childhood, affecting at least one in 50 preschool children.
In the SNIFFLE study, doctors investigated whether the LAIV vaccine was suitable for use in egg-allergic children by giving them the vaccine and closely monitoring them for ill effects afterwards. In total 1,061 children were vaccinated and researchers noted that none suffered from systemic allergic reactions afterwards.
This now means that egg-allergic children can receive the flu vaccine in primary care or in school as part of the national immunisation programme which has led to considerable cost-saving for the NHS.
Assessing a child for attention deficit hyperactivity disorder (ADHD) has typically relied on the clinician’s judgement alongside teacher and parent reports with contradictions in these often leading to delays in diagnosis. The QbTest is a commercially available computer test that measures ADHD symptoms through the combination of a cognitive test designed to measure attention and impulse control, and a motion tracking system to measure hyperactivity.
The AQUA trial set out to put QbTest through its paces asking whether its use could accelerate time to diagnosis. Qualitative interviews and survey data stemming from this research found the test was particularly valued for providing an objective assessment of symptoms. The clinicians were unanimous about the usefulness of the test, finding it helpful to understand symptoms.
The AQUA trial was funded by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, with support from the NIHR MindTech MedTech Co-operative.
You can find out more about Children and Young People studies in your area through the Be Part of Research website.
The Children and Young People's specialty is made up of research-interested clinicians and practitioners at both national and local levels. Our job is to ensure that children's studies receive the right support to ensure they are delivered successfully in the NHS.
We put children and young people at the heart of our work and ensure their involvement at every stage of the design and delivery of our research. We support and deliver clinical research involving children and young people that includes:
In 2006, the Young Persons’ Advisory Group launched and over the years it has become increasingly influential in helping to improve the design and delivery of children and young people's clinical research studies. We have also developed Clinical Studies Groups to provide expert advice to help researchers develop high quality research proposals. There is more information about the Young Persons' Advisory Group and the Clinical Studies Groups on the 'our stakeholders' tab.
Each of our 15 Local Clinical Research Networks has at least one nominated local Clinical Specialty Research Lead for Children. These clinicians lead research groups to promote and support Children research within the NHS Trusts in their area. At a national level the local leads come together to manage the national Children clinical research portfolio. This involves regularly reviewing the progress of studies, identifying barriers to recruitment, and coming up with solutions and strategies to help overcome those barriers. Our National Specialty Group of clinical experts offer advice and support to commercial and non-commercial customers looking to conduct research in the NHS.
To find out more, read our Children and Young People Specialty Profile.
We support the set up and delivery of clinical research in the NHS through our Study Support Service and our Research Design Service helps researchers develop proposals to secure funding from our research programmes.
The NIHR Clinical Research Network Children specialty group works closely with these organisations in integrating clinical research into NHS clinical service provision, and in driving priority setting that encourages research that will have the greatest impact on patients.
Since its launch in 2006, the Young Persons’ Advisory Group (YPAG) has become increasingly influential in helping to improve the design and delivery of children’s clinical research studies. 50-75 young people sit on advisory groups across Liverpool, Birmingham, London, Bristol and Nottingham and meet every six weeks, coming together once a year for a national meeting. The views and opinions expressed by the group feeds into the specialty's Consumer Involvement Steering Group and Board. YPAG supports the clinical research community in a range of ways:
There is more information about the YPAG on their website.
We’ve developed Clinical Studies Groups (CSGs) to cover the different specialty areas within child health. The CSGs provide expert advice to help researchers develop high quality research proposals. Our CSGs include active researchers, parents, nurses, charity representatives and formulation experts. CSGs can help with:
For CSG support for your study, please contact email@example.com for a submission form to provide more information.
NIHR Biomedical Research Centres (BRCs), partnerships between England’s leading NHS organisations and universities, conduct translational research to transform scientific breakthroughs into life-saving treatments for patients with cancer. The following BRCs undertake research in children:
NIHR Applied Research Collaborations (ARCs) support applied health and care research that responds to, and meets, the needs of local populations and local health and care systems. The following ARCs undertake research in children:
NIHR Clinical Research Facilities (CRFs) are dedicated and purpose built facilities where specialist clinical research and support staff from universities and NHS Trusts work together on patient-orientated commercial and non-commercial experimental medicine studies. The following CRFs undertake research in children:
NIHR Medtech and In vitro diagnostics Co-operatives (MICs) build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic tests. The following MICs undertake research in children:
All of the NIHR facilities and centres are opening to working with the public, charities, industry and other partners. If you are interested in collaborating with the NIHR please contact the NIHR Office for Clinical Research infrastructure: firstname.lastname@example.org
Our experts in the NIHR Clinical Research Network (National Specialty Leads) can give advice on delivering your children study in the NHS.
The National Specialty Leads provide leadership on clinical studies in conditions, and act as a key clinical ambassador for these conditions within the specialty.
Professor Paul Dimitri is the NIHR Clinical Research Network National Children’s Specialty Lead. He works at Sheffield Children’s NHS Foundation Trust as a Professor of Child Health, Consultant in Paediatric Endocrinology and Director of Research & Innovation. Paul is the Clinical Lead for the TITCH (Technology Innovation Transforming Child Health) Network established to support the development and adoption of technology for children’s healthcare and the NIHR Children & Young People MedTech Co-operative. Other research positions include Divisional Lead for the Yorkshire & Humber Clinical Research Network and past Deputy Director for the Medicines for Children’s Research Network (East).
News: New rapid genetic test could prevent antibiotic-related hearing loss in newborns
News: NIHR launches campaign to highlight UK expertise in delivering complex and innovative trials
News: Conversation with dental nurse can reduce risk of further tooth decay in young children
Blog: Ability is of little account without opportunity - my journey from clinician to academic
Blog: Increasing diversity in design to accelerate research into practice
Blog: Health in Situations of Fragility: A Systems for Health Approach